A genome-wide RNAi screen identifies novel targets of neratinib resistance leading to identification of potential drug resistant genetic markers†
Abstract
* Corresponding authors
a
Systems Biology, Global Biotherapeutics, Pfizer Inc., 200 Cambridgepark Drive, Cambridge, USA
E-mail:
attila.seyhan@pfizer.com, attila_seyhan@yahoo.com
A. A. Seyhan, U. Varadarajan, S. Choe, W. Liu and T. E. Ryan, Mol. BioSyst., 2012, 8, 1553 DOI: 10.1039/C2MB05512K
To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.
If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.
If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.
Read more about how to correctly acknowledge RSC content.
Fetching data from CrossRef.
This may take some time to load.
Loading related content